Stimulation of the P-450 side chain cleavage enzyme (CYP11A1) promoter through ras- and Ets-2-signaling pathways
Expression of the ovine P-450 side-chain cleavage enzyme gene (CYP11A1) is stimulated by epidermal growth factor (EGF) through a pathway that involves c-Jun in JEG-3 placental cells. Growth factor signaling involves ras-dependent and ras-independent signaling pathways, which in turn regulate gene tr...
Gespeichert in:
Veröffentlicht in: | Molecular endocrinology (Baltimore, Md.) Md.), 1996-09, Vol.10 (9), p.1084-1094 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1094 |
---|---|
container_issue | 9 |
container_start_page | 1084 |
container_title | Molecular endocrinology (Baltimore, Md.) |
container_volume | 10 |
creator | Pestell, R G Albanese, C Watanabe, G Lee, R J Lastowiecki, P Zon, L Ostrowski, M Jameson, J L |
description | Expression of the ovine P-450 side-chain cleavage enzyme gene (CYP11A1) is stimulated by epidermal growth factor (EGF) through a pathway that involves c-Jun in JEG-3 placental cells. Growth factor signaling involves ras-dependent and ras-independent signaling pathways, which in turn regulate gene transcription through related but distinct mitogen-activated protein kinase pathways (MAPKs) including the extracellular signal-regulated kinases (ERKs) and the stress-activated protein kinases (SAPKs). We investigated the intracellular signaling pathways governing EGF induction of the CYP11A1 promoter. EGF stimulation of the CYP11A1 promoter (4-fold) was reduced 60% by a dominant negative mutant of ras (N17), and 30-40% by antisense ras. EGF induced both ERK and SAPK activity in JEG-3 cells. EGF-induced CYP11A1 promoter activity was reduced 60% by the MEK1 inhibitor PD098059 and 50% by a dominant negative mutant of the ERK-specific regulator MEK1. In contrast, dominant negative mutants of the SAPK-specific activator, SEK1, induced a further increase in EGF-induced CYP11A1 promoter activity. Constitutively active mutants of ras (V12 or L61) increased CYP11A1 promoter activity 6- to 8-fold. Deletion of the EGF response element (EGF-RE) between -92 and -77 bp reduced ras induction by 60%; however, a residual 3-fold induction remained through the proximal -77 bp. Mutation of the EGF-RE AP-1-like sequence in the context of the native promoter reduced CYP11A1 promoter activation by ras 60%. The EGF-RE sequence was sufficient for 6-fold activation by ras in the context of an heterologous thymidine kinase promoter. Candidate transcription factor targets (c-Jun, c-Ets-2) for the ras-signaling cascade were examined for their effects on CYP11A1 promoter activity. Overexpression of c-Jun induced the CYP11A1 promoter through the EGF-RE; however, c-Ets-2 activation of the CYP11A1 promoter (12-fold) required the proximal ras-responsive promoter sequences that are distinct from the EGF/MEK/c-Jun-responsive element. Induction of the CYP11A1 promoter by EGF involves a ras/MEK1/AP-1-dependent pathway that is distinct from induction by ras/c-Ets-2. |
doi_str_mv | 10.1210/me.10.9.1084 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78468516</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78468516</sourcerecordid><originalsourceid>FETCH-LOGICAL-c286t-c67161d5d098f52ac5d03edb61fb0d394d5bdfe5a79b2bd756f808403814e93</originalsourceid><addsrcrecordid>eNo9kM9LwzAUx3NQ5pzevAo5iYKZSdu06VHG_AEDB_PiqaTNaxtp2pmkyvzrzdjw8t6Xx-d9ee-L0BWjcxYx-mBgHmQeikhO0JQKIYgQND9D5859UsoSLtgETcKcR0k8RduN12bspNdDj4ca-xbwmiScYqcV4KqVusdVB_JbNoCh_90ZwLeLjzVjj-wOb-1gBg827NlhbFpspSNY9govvSMRcbrpZaf7Bm-lb3_kzl2g01p2Di6PfYY2T8v3xQtZvT2_Lh5XpIpE6kmVZixliiuai5pHsgoqBlWmrC6pivNE8VLVwGWWl1GpMp7WIvxMY8ESyOMZujm4hgO_RnC-MNpV0HWyh2F0RSaSVHCWBvD-AFZ2cM5CXWytNtLuCkaLfaSFgb3Mi32kAb8--o6lAfUPH_OM_wBTFnLS</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78468516</pqid></control><display><type>article</type><title>Stimulation of the P-450 side chain cleavage enzyme (CYP11A1) promoter through ras- and Ets-2-signaling pathways</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Pestell, R G ; Albanese, C ; Watanabe, G ; Lee, R J ; Lastowiecki, P ; Zon, L ; Ostrowski, M ; Jameson, J L</creator><creatorcontrib>Pestell, R G ; Albanese, C ; Watanabe, G ; Lee, R J ; Lastowiecki, P ; Zon, L ; Ostrowski, M ; Jameson, J L</creatorcontrib><description>Expression of the ovine P-450 side-chain cleavage enzyme gene (CYP11A1) is stimulated by epidermal growth factor (EGF) through a pathway that involves c-Jun in JEG-3 placental cells. Growth factor signaling involves ras-dependent and ras-independent signaling pathways, which in turn regulate gene transcription through related but distinct mitogen-activated protein kinase pathways (MAPKs) including the extracellular signal-regulated kinases (ERKs) and the stress-activated protein kinases (SAPKs). We investigated the intracellular signaling pathways governing EGF induction of the CYP11A1 promoter. EGF stimulation of the CYP11A1 promoter (4-fold) was reduced 60% by a dominant negative mutant of ras (N17), and 30-40% by antisense ras. EGF induced both ERK and SAPK activity in JEG-3 cells. EGF-induced CYP11A1 promoter activity was reduced 60% by the MEK1 inhibitor PD098059 and 50% by a dominant negative mutant of the ERK-specific regulator MEK1. In contrast, dominant negative mutants of the SAPK-specific activator, SEK1, induced a further increase in EGF-induced CYP11A1 promoter activity. Constitutively active mutants of ras (V12 or L61) increased CYP11A1 promoter activity 6- to 8-fold. Deletion of the EGF response element (EGF-RE) between -92 and -77 bp reduced ras induction by 60%; however, a residual 3-fold induction remained through the proximal -77 bp. Mutation of the EGF-RE AP-1-like sequence in the context of the native promoter reduced CYP11A1 promoter activation by ras 60%. The EGF-RE sequence was sufficient for 6-fold activation by ras in the context of an heterologous thymidine kinase promoter. Candidate transcription factor targets (c-Jun, c-Ets-2) for the ras-signaling cascade were examined for their effects on CYP11A1 promoter activity. Overexpression of c-Jun induced the CYP11A1 promoter through the EGF-RE; however, c-Ets-2 activation of the CYP11A1 promoter (12-fold) required the proximal ras-responsive promoter sequences that are distinct from the EGF/MEK/c-Jun-responsive element. Induction of the CYP11A1 promoter by EGF involves a ras/MEK1/AP-1-dependent pathway that is distinct from induction by ras/c-Ets-2.</description><identifier>ISSN: 0888-8809</identifier><identifier>DOI: 10.1210/me.10.9.1084</identifier><identifier>PMID: 8885243</identifier><language>eng</language><publisher>United States</publisher><subject>Calcium-Calmodulin-Dependent Protein Kinases - genetics ; Calcium-Calmodulin-Dependent Protein Kinases - metabolism ; Cholesterol Side-Chain Cleavage Enzyme - drug effects ; Cholesterol Side-Chain Cleavage Enzyme - genetics ; Cholesterol Side-Chain Cleavage Enzyme - metabolism ; Choriocarcinoma - genetics ; Choriocarcinoma - metabolism ; Choriocarcinoma - pathology ; DNA-Binding Proteins ; Epidermal Growth Factor - metabolism ; Epidermal Growth Factor - pharmacology ; Gene Expression Regulation ; Genes, jun ; Genes, ras ; Humans ; JNK Mitogen-Activated Protein Kinases ; MAP Kinase Kinase Kinase 1 ; Mitogen-Activated Protein Kinases ; Promoter Regions, Genetic ; Protein-Serine-Threonine Kinases - genetics ; Protein-Serine-Threonine Kinases - metabolism ; Proto-Oncogene Protein c-ets-2 ; Proto-Oncogene Proteins - genetics ; Proto-Oncogene Proteins - metabolism ; Repressor Proteins ; Sequence Deletion ; Signal Transduction ; Trans-Activators - genetics ; Trans-Activators - metabolism ; Transcription Factor AP-1 - genetics ; Transcription Factor AP-1 - metabolism ; Transcription Factors ; Transcription, Genetic - drug effects ; Tumor Cells, Cultured</subject><ispartof>Molecular endocrinology (Baltimore, Md.), 1996-09, Vol.10 (9), p.1084-1094</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c286t-c67161d5d098f52ac5d03edb61fb0d394d5bdfe5a79b2bd756f808403814e93</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8885243$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pestell, R G</creatorcontrib><creatorcontrib>Albanese, C</creatorcontrib><creatorcontrib>Watanabe, G</creatorcontrib><creatorcontrib>Lee, R J</creatorcontrib><creatorcontrib>Lastowiecki, P</creatorcontrib><creatorcontrib>Zon, L</creatorcontrib><creatorcontrib>Ostrowski, M</creatorcontrib><creatorcontrib>Jameson, J L</creatorcontrib><title>Stimulation of the P-450 side chain cleavage enzyme (CYP11A1) promoter through ras- and Ets-2-signaling pathways</title><title>Molecular endocrinology (Baltimore, Md.)</title><addtitle>Mol Endocrinol</addtitle><description>Expression of the ovine P-450 side-chain cleavage enzyme gene (CYP11A1) is stimulated by epidermal growth factor (EGF) through a pathway that involves c-Jun in JEG-3 placental cells. Growth factor signaling involves ras-dependent and ras-independent signaling pathways, which in turn regulate gene transcription through related but distinct mitogen-activated protein kinase pathways (MAPKs) including the extracellular signal-regulated kinases (ERKs) and the stress-activated protein kinases (SAPKs). We investigated the intracellular signaling pathways governing EGF induction of the CYP11A1 promoter. EGF stimulation of the CYP11A1 promoter (4-fold) was reduced 60% by a dominant negative mutant of ras (N17), and 30-40% by antisense ras. EGF induced both ERK and SAPK activity in JEG-3 cells. EGF-induced CYP11A1 promoter activity was reduced 60% by the MEK1 inhibitor PD098059 and 50% by a dominant negative mutant of the ERK-specific regulator MEK1. In contrast, dominant negative mutants of the SAPK-specific activator, SEK1, induced a further increase in EGF-induced CYP11A1 promoter activity. Constitutively active mutants of ras (V12 or L61) increased CYP11A1 promoter activity 6- to 8-fold. Deletion of the EGF response element (EGF-RE) between -92 and -77 bp reduced ras induction by 60%; however, a residual 3-fold induction remained through the proximal -77 bp. Mutation of the EGF-RE AP-1-like sequence in the context of the native promoter reduced CYP11A1 promoter activation by ras 60%. The EGF-RE sequence was sufficient for 6-fold activation by ras in the context of an heterologous thymidine kinase promoter. Candidate transcription factor targets (c-Jun, c-Ets-2) for the ras-signaling cascade were examined for their effects on CYP11A1 promoter activity. Overexpression of c-Jun induced the CYP11A1 promoter through the EGF-RE; however, c-Ets-2 activation of the CYP11A1 promoter (12-fold) required the proximal ras-responsive promoter sequences that are distinct from the EGF/MEK/c-Jun-responsive element. Induction of the CYP11A1 promoter by EGF involves a ras/MEK1/AP-1-dependent pathway that is distinct from induction by ras/c-Ets-2.</description><subject>Calcium-Calmodulin-Dependent Protein Kinases - genetics</subject><subject>Calcium-Calmodulin-Dependent Protein Kinases - metabolism</subject><subject>Cholesterol Side-Chain Cleavage Enzyme - drug effects</subject><subject>Cholesterol Side-Chain Cleavage Enzyme - genetics</subject><subject>Cholesterol Side-Chain Cleavage Enzyme - metabolism</subject><subject>Choriocarcinoma - genetics</subject><subject>Choriocarcinoma - metabolism</subject><subject>Choriocarcinoma - pathology</subject><subject>DNA-Binding Proteins</subject><subject>Epidermal Growth Factor - metabolism</subject><subject>Epidermal Growth Factor - pharmacology</subject><subject>Gene Expression Regulation</subject><subject>Genes, jun</subject><subject>Genes, ras</subject><subject>Humans</subject><subject>JNK Mitogen-Activated Protein Kinases</subject><subject>MAP Kinase Kinase Kinase 1</subject><subject>Mitogen-Activated Protein Kinases</subject><subject>Promoter Regions, Genetic</subject><subject>Protein-Serine-Threonine Kinases - genetics</subject><subject>Protein-Serine-Threonine Kinases - metabolism</subject><subject>Proto-Oncogene Protein c-ets-2</subject><subject>Proto-Oncogene Proteins - genetics</subject><subject>Proto-Oncogene Proteins - metabolism</subject><subject>Repressor Proteins</subject><subject>Sequence Deletion</subject><subject>Signal Transduction</subject><subject>Trans-Activators - genetics</subject><subject>Trans-Activators - metabolism</subject><subject>Transcription Factor AP-1 - genetics</subject><subject>Transcription Factor AP-1 - metabolism</subject><subject>Transcription Factors</subject><subject>Transcription, Genetic - drug effects</subject><subject>Tumor Cells, Cultured</subject><issn>0888-8809</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kM9LwzAUx3NQ5pzevAo5iYKZSdu06VHG_AEDB_PiqaTNaxtp2pmkyvzrzdjw8t6Xx-d9ee-L0BWjcxYx-mBgHmQeikhO0JQKIYgQND9D5859UsoSLtgETcKcR0k8RduN12bspNdDj4ca-xbwmiScYqcV4KqVusdVB_JbNoCh_90ZwLeLjzVjj-wOb-1gBg827NlhbFpspSNY9govvSMRcbrpZaf7Bm-lb3_kzl2g01p2Di6PfYY2T8v3xQtZvT2_Lh5XpIpE6kmVZixliiuai5pHsgoqBlWmrC6pivNE8VLVwGWWl1GpMp7WIvxMY8ESyOMZujm4hgO_RnC-MNpV0HWyh2F0RSaSVHCWBvD-AFZ2cM5CXWytNtLuCkaLfaSFgb3Mi32kAb8--o6lAfUPH_OM_wBTFnLS</recordid><startdate>19960901</startdate><enddate>19960901</enddate><creator>Pestell, R G</creator><creator>Albanese, C</creator><creator>Watanabe, G</creator><creator>Lee, R J</creator><creator>Lastowiecki, P</creator><creator>Zon, L</creator><creator>Ostrowski, M</creator><creator>Jameson, J L</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19960901</creationdate><title>Stimulation of the P-450 side chain cleavage enzyme (CYP11A1) promoter through ras- and Ets-2-signaling pathways</title><author>Pestell, R G ; Albanese, C ; Watanabe, G ; Lee, R J ; Lastowiecki, P ; Zon, L ; Ostrowski, M ; Jameson, J L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c286t-c67161d5d098f52ac5d03edb61fb0d394d5bdfe5a79b2bd756f808403814e93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Calcium-Calmodulin-Dependent Protein Kinases - genetics</topic><topic>Calcium-Calmodulin-Dependent Protein Kinases - metabolism</topic><topic>Cholesterol Side-Chain Cleavage Enzyme - drug effects</topic><topic>Cholesterol Side-Chain Cleavage Enzyme - genetics</topic><topic>Cholesterol Side-Chain Cleavage Enzyme - metabolism</topic><topic>Choriocarcinoma - genetics</topic><topic>Choriocarcinoma - metabolism</topic><topic>Choriocarcinoma - pathology</topic><topic>DNA-Binding Proteins</topic><topic>Epidermal Growth Factor - metabolism</topic><topic>Epidermal Growth Factor - pharmacology</topic><topic>Gene Expression Regulation</topic><topic>Genes, jun</topic><topic>Genes, ras</topic><topic>Humans</topic><topic>JNK Mitogen-Activated Protein Kinases</topic><topic>MAP Kinase Kinase Kinase 1</topic><topic>Mitogen-Activated Protein Kinases</topic><topic>Promoter Regions, Genetic</topic><topic>Protein-Serine-Threonine Kinases - genetics</topic><topic>Protein-Serine-Threonine Kinases - metabolism</topic><topic>Proto-Oncogene Protein c-ets-2</topic><topic>Proto-Oncogene Proteins - genetics</topic><topic>Proto-Oncogene Proteins - metabolism</topic><topic>Repressor Proteins</topic><topic>Sequence Deletion</topic><topic>Signal Transduction</topic><topic>Trans-Activators - genetics</topic><topic>Trans-Activators - metabolism</topic><topic>Transcription Factor AP-1 - genetics</topic><topic>Transcription Factor AP-1 - metabolism</topic><topic>Transcription Factors</topic><topic>Transcription, Genetic - drug effects</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pestell, R G</creatorcontrib><creatorcontrib>Albanese, C</creatorcontrib><creatorcontrib>Watanabe, G</creatorcontrib><creatorcontrib>Lee, R J</creatorcontrib><creatorcontrib>Lastowiecki, P</creatorcontrib><creatorcontrib>Zon, L</creatorcontrib><creatorcontrib>Ostrowski, M</creatorcontrib><creatorcontrib>Jameson, J L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular endocrinology (Baltimore, Md.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pestell, R G</au><au>Albanese, C</au><au>Watanabe, G</au><au>Lee, R J</au><au>Lastowiecki, P</au><au>Zon, L</au><au>Ostrowski, M</au><au>Jameson, J L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Stimulation of the P-450 side chain cleavage enzyme (CYP11A1) promoter through ras- and Ets-2-signaling pathways</atitle><jtitle>Molecular endocrinology (Baltimore, Md.)</jtitle><addtitle>Mol Endocrinol</addtitle><date>1996-09-01</date><risdate>1996</risdate><volume>10</volume><issue>9</issue><spage>1084</spage><epage>1094</epage><pages>1084-1094</pages><issn>0888-8809</issn><abstract>Expression of the ovine P-450 side-chain cleavage enzyme gene (CYP11A1) is stimulated by epidermal growth factor (EGF) through a pathway that involves c-Jun in JEG-3 placental cells. Growth factor signaling involves ras-dependent and ras-independent signaling pathways, which in turn regulate gene transcription through related but distinct mitogen-activated protein kinase pathways (MAPKs) including the extracellular signal-regulated kinases (ERKs) and the stress-activated protein kinases (SAPKs). We investigated the intracellular signaling pathways governing EGF induction of the CYP11A1 promoter. EGF stimulation of the CYP11A1 promoter (4-fold) was reduced 60% by a dominant negative mutant of ras (N17), and 30-40% by antisense ras. EGF induced both ERK and SAPK activity in JEG-3 cells. EGF-induced CYP11A1 promoter activity was reduced 60% by the MEK1 inhibitor PD098059 and 50% by a dominant negative mutant of the ERK-specific regulator MEK1. In contrast, dominant negative mutants of the SAPK-specific activator, SEK1, induced a further increase in EGF-induced CYP11A1 promoter activity. Constitutively active mutants of ras (V12 or L61) increased CYP11A1 promoter activity 6- to 8-fold. Deletion of the EGF response element (EGF-RE) between -92 and -77 bp reduced ras induction by 60%; however, a residual 3-fold induction remained through the proximal -77 bp. Mutation of the EGF-RE AP-1-like sequence in the context of the native promoter reduced CYP11A1 promoter activation by ras 60%. The EGF-RE sequence was sufficient for 6-fold activation by ras in the context of an heterologous thymidine kinase promoter. Candidate transcription factor targets (c-Jun, c-Ets-2) for the ras-signaling cascade were examined for their effects on CYP11A1 promoter activity. Overexpression of c-Jun induced the CYP11A1 promoter through the EGF-RE; however, c-Ets-2 activation of the CYP11A1 promoter (12-fold) required the proximal ras-responsive promoter sequences that are distinct from the EGF/MEK/c-Jun-responsive element. Induction of the CYP11A1 promoter by EGF involves a ras/MEK1/AP-1-dependent pathway that is distinct from induction by ras/c-Ets-2.</abstract><cop>United States</cop><pmid>8885243</pmid><doi>10.1210/me.10.9.1084</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0888-8809 |
ispartof | Molecular endocrinology (Baltimore, Md.), 1996-09, Vol.10 (9), p.1084-1094 |
issn | 0888-8809 |
language | eng |
recordid | cdi_proquest_miscellaneous_78468516 |
source | MEDLINE; Oxford University Press Journals All Titles (1996-Current) |
subjects | Calcium-Calmodulin-Dependent Protein Kinases - genetics Calcium-Calmodulin-Dependent Protein Kinases - metabolism Cholesterol Side-Chain Cleavage Enzyme - drug effects Cholesterol Side-Chain Cleavage Enzyme - genetics Cholesterol Side-Chain Cleavage Enzyme - metabolism Choriocarcinoma - genetics Choriocarcinoma - metabolism Choriocarcinoma - pathology DNA-Binding Proteins Epidermal Growth Factor - metabolism Epidermal Growth Factor - pharmacology Gene Expression Regulation Genes, jun Genes, ras Humans JNK Mitogen-Activated Protein Kinases MAP Kinase Kinase Kinase 1 Mitogen-Activated Protein Kinases Promoter Regions, Genetic Protein-Serine-Threonine Kinases - genetics Protein-Serine-Threonine Kinases - metabolism Proto-Oncogene Protein c-ets-2 Proto-Oncogene Proteins - genetics Proto-Oncogene Proteins - metabolism Repressor Proteins Sequence Deletion Signal Transduction Trans-Activators - genetics Trans-Activators - metabolism Transcription Factor AP-1 - genetics Transcription Factor AP-1 - metabolism Transcription Factors Transcription, Genetic - drug effects Tumor Cells, Cultured |
title | Stimulation of the P-450 side chain cleavage enzyme (CYP11A1) promoter through ras- and Ets-2-signaling pathways |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T14%3A04%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Stimulation%20of%20the%20P-450%20side%20chain%20cleavage%20enzyme%20(CYP11A1)%20promoter%20through%20ras-%20and%20Ets-2-signaling%20pathways&rft.jtitle=Molecular%20endocrinology%20(Baltimore,%20Md.)&rft.au=Pestell,%20R%20G&rft.date=1996-09-01&rft.volume=10&rft.issue=9&rft.spage=1084&rft.epage=1094&rft.pages=1084-1094&rft.issn=0888-8809&rft_id=info:doi/10.1210/me.10.9.1084&rft_dat=%3Cproquest_cross%3E78468516%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78468516&rft_id=info:pmid/8885243&rfr_iscdi=true |